Emerging Drug Developers

Our weekly series on emerging biotech companies will give you insight into who's running the most promising new biotech and pharma companies in the industry today.

If you have any suggestions of companies you'd like to see profiled, be sure to let us know.   

May 12, 2008: Resolvyx Pharmaceuticals
May 5, 2008: Concert Pharmaceuticals
April 28, 2008: Argos Therapeutics
April 21, 2008: Aileron Therapeutics
April 14, 2008: Epix Pharmaceuticals
April 7, 2008: Transave
March 31, 2008: Trius Therapeutics
March 24, 2008 Iomai
March 17, 2008: Transition Therapeutics
March 10, 2008: BrainCells
March 3, 2008: CombinatoRx
February 25, 2008: Ocera Therapeutics
February 11, 2008: Promedior
February 4, 2008: Sonexa Therapeutics
January 27, 2008: Genaera
January 14, 2008: Addex Pharmaceuticals
January 7, 2008: Fovea Pharmaceuticals 
December 14, 2007: Ambit Biosciences
December 7, 2007: Relypsa
November 30, 2007: Bind Biosciences
November 16, 2007: LEAD Therapeutics
November 9, 2007: MediQuest
Novermber 2, 2007: Acceleron
October 26, 2007: Tolerx
October 19, 2007: Tengion
October 12, 2007: Optherion
October 5, 2007: Argos Therapeutics
September 28, 2007: GlobeImmune
September 14, 2007: Enobia
September 7, 2007: NeurAxon
August 31, 2007: Hollis-Eden
August 24, 2007: Serentis
August 17, 2007: Horizon Therapeutics
August 10, 2007: Koronis Pharmaceuticals